
|Articles|April 1, 2003
Technology in trials: Early results promising for presbyopia reversal
Orlando-Early results from a clinical trial for the reversal and treatment of presbyopia, using SurgiLight Inc.'s OptiVision technology, appear "promising," according to researchers at New York-Presbyterian Hospital Weill Cornell Medical Center.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What if? Ophthalmology without OCT – Part 5
2
LASIK and beyond: Navigating the changing landscape of refractive surgery
3
Transformative advances in vision research: It’s the science
4
Q&A: James Chelnis discusses AAO 2025 presentation on aesthetic facial surgery
5


















































.png)


